D
Solid Biosciences Inc. SLDB
$3.16 -$0.245-7.20%
Recommendation
Sell
Prev Close
$3.41
Volume
812,632
Avg Vol (90D)
1,786,576
Market Cap
$263.86M
Dividend & Yield
--
52-Week Range
$2.88 - $12.95
P/E (TTM)
--
EPS (TTM)
-$3.04
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
2/19/2025 - MarketBeat
Solid Biosciences (SLDB, $3.41) Aroon Indicator entered a Downtrend on April 03, 2025.
4/4/2025 - Tickeron - Stocks
Solid Biosciences (SLDB, $3.41) RSI Indicator left the oversold zone on April 03, 2025
4/4/2025 - Tickeron - Stocks
Solid Biosciences (SLDB, $3.69) Aroon Indicator entered a Downtrend on April 02, 2025.
4/3/2025 - Tickeron - Stocks
Solid Biosciences (SLDB, $3.69) RSI Indicator left the oversold zone on April 02, 2025
4/3/2025 - Tickeron - Stocks
Solid Biosciences Advances Gene Therapy Pipeline
4/3/2025 - TipRanks Financial Blog
Solid Biosciences (SLDB, $3.45) Aroon Indicator entered a Downtrend on April 01, 2025.
4/2/2025 - Tickeron - Stocks
Solid Biosciences reports inducement grants under Nasdaq listing rule
4/1/2025 - The Fly
Solid Biosciences (SLDB, $3.7) Aroon Indicator entered a Downtrend on March 31, 2025.
4/1/2025 - Tickeron - Stocks
Solid Biosciences (SLDB, $3.7) price may climb as it broke lower Bollinger Band on Mar 31, 2025
4/1/2025 - Tickeron - Stocks
Solid Biosciences (SLDB, $3.7) RSI Indicator left the oversold zone on March 31, 2025
4/1/2025 - Tickeron - Stocks
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/1/2025 - GuruFocus
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/1/2025 - Globe Newswire
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
4/1/2025 - Globe Newswire
Solid Biosciences (SLDB, $4.32) Aroon Indicator entered a Downtrend on March 28, 2025.
3/29/2025 - Tickeron - Technical Analysis
Solid Biosciences (SLDB, $4.37) Aroon Indicator entered a Downtrend on March 27, 2025.
3/28/2025 - Tickeron - Technical Analysis
Solid Biosciences (NASDAQ:SLDB) & AlloVir (NASDAQ:ALVR) Critical Survey
3/25/2025 - Ticker Report
How to Play SRPT Stock After Patient Death Post DMD Therapy Infusion
3/24/2025 - Zacks Investment Research
Solid Biosciences Inc.'s (NASDAQ:SLDB) market cap dropped US$53m last week; Private equity firms bore the brunt
3/19/2025 - Simply Wall St
Solid Biosciences (SLDB, $4.93) entered Downtrend as Momentum indicator drops below 0 level on Mar 18, 2025
3/19/2025 - Tickeron - Stocks
Solid Biosciences (SLDB, $5.36) entered Uptrend as Momentum indicator ascends above 0 level on Mar 17, 2025
3/18/2025 - Tickeron - Technical Analysis
Solid Biosciences Inc. (SLDB): Among Top Insider Purchases Last Month
3/15/2025 - Insider Monkey
JPMorgan Chase & Co. Issues Pessimistic Forecast for Solid Biosciences (NASDAQ:SLDB) Stock Price
3/14/2025 - MarketBeat
Solid Biosciences (SLDB, $5.15) entered Downtrend as Momentum indicator drops below 0 level on Mar 13, 2025
3/14/2025 - Tickeron - Stocks
Solid Biosciences (NASDAQ:SLDB) Stock Price Up 0.5% - Still a Buy?
3/13/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$127.27M
EBIT (TTM)
-$129.73M
Net Income (TTM)
-$124.70M
Balance Sheet
Total Assets (Q)
$188.66M
Total Debt (Q)
$24.18M
Total Liabilities (Q)
$51.42M
Book Value Per Share (Q)
$3.39
Cash Flow
Cash from Operations (TTM)
-$100.01M
Cash from Investing (TTM)
-$16.09M
Cash from Financing (TTM)
$122.44M
Net Change in Cash (TTM)
$6.34M
Filings
Filing Date
Thursday, March 6, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
2.95
7-Day Total Return
-25.82%
30-Day Total Return
-45.33%
60-Day Total Return
-19.39%
90-Day Total Return
-39.58%
Year to Date Total Return
-18.97%
1-Year Total Return
-74.47%
2-Year Total Return
-33.47%
3-Year Total Return
-83.01%
5-Year Total Return
-90.72%
52-week Low
Feb 07, 2025 - $2.88
52-week High
Apr 04, 2024 - $12.95
Valuation
Market Cap
$263.86M - Micro Cap
Enterprise Value
$139.12M
Price/Sales (TTM)
--
Price/Book (Q)
1.00
Dividends and Shares
Shares Outstanding
42.71M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.solidbio.com
Phone Number
617 337 4680
Address
500 Rutherford Avenue
Charlestown, MA 02129
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company’s lead product candidate is SGT-003, which is in phase 1/2 for the treatment of... more
NASDAQ 04/04/2025 1:33PM Eastern Quotes delayed
Weiss Ratings